摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-carbamoyl-2,2-dimethyl-5,5-dimethoxy-3-imidazolin-1-yloxy | 138001-13-5

中文名称
——
中文别名
——
英文名称
4-carbamoyl-2,2-dimethyl-5,5-dimethoxy-3-imidazolin-1-yloxy
英文别名
2,2-dimethyl-5,5-dimethoxy-4-amido-3-imidazoline-1-oxyl;4-amido-2,2-dimethyl-5,5-dimethoxy-3-imidazoline-1-oxyl
4-carbamoyl-2,2-dimethyl-5,5-dimethoxy-3-imidazolin-1-yloxy化学式
CAS
138001-13-5
化学式
C8H14N3O4
mdl
——
分子量
216.217
InChiKey
RVNGYJDGAQFMML-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.74
  • 重原子数:
    15.0
  • 可旋转键数:
    3.0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.75
  • 拓扑面积:
    97.05
  • 氢给体数:
    1.0
  • 氢受体数:
    5.0

反应信息

  • 作为反应物:
    描述:
    4-carbamoyl-2,2-dimethyl-5,5-dimethoxy-3-imidazolin-1-yloxy氯化铵 作用下, 以 甲醇 为溶剂, 以90%的产率得到5-Methoxy-2,2-dimethyl-1-oxy-2H-imidazole-4-carboxylic acid amide
    参考文献:
    名称:
    Reduction of α,α-dialkoxy-substituted nitroxides: the synthesis of α-alkoxynitrones and acetals ofN-hydroxyamides
    摘要:
    Reduction of stable nitroxides derived from tetrahydrooxazole, tetrahydroimidazole, 2,5-dihydroimidazole, and 2,5-dihydroimidazole 3-oxide containing alkoxy groups in alpha-position to the nitroxyl group affords alpha-alkoxynitrones, acetals of N-hydroxyamides, or their equilibrium mixtures.
    DOI:
    10.1007/bf02494863
  • 作为产物:
    参考文献:
    名称:
    Synthesis of 2H-imidazole 1-oxides and stable nitroxyl radicals based on them
    摘要:
    2H-Imidazole 1-oxides containing an aldonitrone group in the heterocyclic ring are obtained by the condensation of hydroximinomethyl ketones with ketones and ammonium acetate. Their oxidation with lead dioxide in methanol gives stable nitroxyl radicals - 5,5-dimethoxy-3-imidazoline-1-oxyls.
    DOI:
    10.1007/bf00960421
点击查看最新优质反应信息

文献信息

  • Burdukov, A. B.; Ovcharenko, V.I.; Pervukhina, N. V., Russian Journal of Inorganic Chemistry, 1993, vol. 38, p. 460 - 465
    作者:Burdukov, A. B.、Ovcharenko, V.I.、Pervukhina, N. V.、Ikorskii, V. N.
    DOI:——
    日期:——
  • Burdukov; Ovcharenko; Pervukhina, Russian Journal of Inorganic Chemistry, 1999, vol. 44, # 7, p. 1064 - 1071
    作者:Burdukov、Ovcharenko、Pervukhina、Ikorskii、Grigor'ev、Kirilyuk、Ovcharenko、Musin
    DOI:——
    日期:——
  • Two Cu(hfac)2 complexes with the imidazoline nitroxide 4-amido-2,2-dimethyl-5,5-dimethoxy-3-imidazoline-1-oxyl. Conversion of a discrete molecular structure to a chain structure as a result of stoichiometric changes
    作者:Alexei B. Burdukov、Victor I. Ovcharenko、Renad Z. Sagdeev、Alexei V. Podoplelov、Natalie V. Pervukhina、Vladimir N. Ikorskii、Igor A. Kiriluk、Igor A. Grigoriev
    DOI:10.1016/0277-5387(94)00273-h
    日期:1995.2
    The reaction of copper hexafluoroacetylacetonate with the stable nitroxide 4-amido-2,2-dimethyl-5,5-dimethoxy-3-imidazoline-1-oxyl (L) in a ratio of 2:1 in hexane yielded the Cu(hfac)(2)-saturated coordination chain polymer of composition [Cu(hfac)(2)](2)L. In [Cu(hfac)(2)](2)L, half of the Cu(hfac)(2) molecules coordinate L in bidentate-fashion by the amide-group oxygen and the imine nitrogen of the heterocycle. The other Cu(hfac)(2) molecules arrange the above Cu(hfac)(2)L} fragments in polymer chains by alternate coordination of either the N-O group, or the amide-group oxygens of two Cu(hfac)(2)L} fragments to axial positions. As a result [Cu(hfac)(2)](2)L involves three copper ions with coordination number 6 and with different coordination environments. For metal complexes with nitroxides, this mode of chain formation was observed for the first time. The magnetic properties of the complex are described in terms of an exchange cluster model with ferromagnetic intracluster exchange interactions.
查看更多

同类化合物

(4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] 香豆素-6-羧酸 顺式-3a,5,6,6a-四氢-3-(1-甲基乙基)-4H-环戊二烯并[d]异恶唑 锌离子载体IV 钐(III) 离子载体 II 苯,1-(2E)-2-丁烯-1-基-2-氟- 苯,(2,2-二氟乙烯基)- 聚二硫二噻唑烷 缩胆囊肽9 绕丹酸钠 盐(1:?)5'-尿苷酸,钠 甲酰乙内脲 甲巯咪唑 甲基羟甲基油基噁唑啉 甲基5-羟基-3,5-二甲基-4,5-二氢-1H-吡唑-1-羧酸酯 甲基5-甲基-4,5-二氢-1H-吡唑-3-羧酸酯 甲基5-甲基-4,5-二氢-1H-吡唑-1-羧酸酯 甲基5-氰基-4,5-二氢-1,2-恶唑-3-羧酸酯 甲基5-乙炔基-4,5-二氢-1H-吡唑-3-羧酸酯 甲基5-(羟基甲基)-4,5-二氢-1,2-恶唑-3-羧酸酯 甲基4-甲基-5-氧代-4,5-二氢-1H-吡唑-3-羧酸酯 甲基4-甲基-4,5-二氢-1H-吡唑-3-羧酸酯 甲基4-乙炔基-4,5-二氢-1H-吡唑-3-羧酸酯 甲基4,5-二氮杂螺[2.4]庚-5-烯-6-羧酸酯 甲基4,5-二氢-5-乙基-1H-吡唑-1-羧酸酯 甲基3-甲基-4,5-二氢-1,2-恶唑-4-羧酸酯 甲基(E)-3-[6-[1-羟基-1-(4-甲基苯基)-3-(1-吡咯烷基)丙基]-2-吡啶基]丙烯酰酸酯 甲基(5-氧代-4,5-二氢-1,2-恶唑-3-基)乙酸酯 环戊二烯并[d]咪唑-2,5(1H,3H)-二硫酮 环己羧酸,3-氨基-2-甲氧基-,甲基酯,(1S,2S,3S)- 溶剂黄93 溴化1-十六烷基-3-甲基咪唑 溴化1-十二烷基-2,3-二甲基咪唑 泰比培南酯中间体 泰比培南酯中间体 氨甲酸,[4,5-二氢-4-(碘甲基)-2-噻唑基]-,1,1-二甲基乙基酯(9CI) 氨基甲硫酸,[2-[[(2-羰基-1-咪唑烷基)硫代甲基]氨基]乙基]-,O-甲基酯 异噻唑,4,5-二氯-2,5-二氢-2-辛基- 希诺米啉 四氟硼酸二氢1,3-二(叔-丁基)-4,5--1H-咪唑正离子 四唑硝基紫 噻唑烷-2,4-二酮-2-缩氨基脲 噻唑丁炎酮 噻唑,4,5-二氢-4-(1-甲基乙基)-,(S)- 噁唑,4,5-二氢-4,4-二甲基-2-(5-甲基-2-呋喃基)- 噁唑,2-庚基-4,5-二氢- 咪唑烷基脲 吡嗪,2,3-二氢-5,6-二甲基-2-丙基- 叔-丁基3-羟基-1,4,6,7-四氢吡唑并[4,3-c]吡啶-5-羧酸酯 双吡唑啉酮